Pilocarpine Ophthalmic — Membership Pricing

Other medications in Eye & Vision

• Prednisolone Acetate Ophthalmic
• Brimonidine Ophthalmic
• Nepafenac
• Olopatadine

About Pilocarpine Ophthalmic

Pilocarpine ophthalmic is a crucial medication primarily used to manage specific eye conditions, helping to maintain healthy vision. Navigating prescription costs can be challenging, but TheDrugClub is here to help. Discover how our membership program can provide significant savings on essential medications like pilocarpine ophthalmic, making your eye care more accessible and affordable.

Pilocarpine Ophthalmic: Your Partner in Eye Health

Pilocarpine ophthalmic is an important medication often prescribed to manage conditions that affect eye pressure. If you've been prescribed this medication, understanding what it treats, how it works, and how to manage its cost can empower you in your healthcare journey.

What Pilocarpine Ophthalmic Treats

Pilocarpine ophthalmic is primarily used to treat glaucoma, a group of eye conditions that damage the optic nerve, often due to abnormally high pressure in your eye. Specifically, it's effective in managing:

• Open-angle glaucoma: The most common form of glaucoma, where the drainage angle for the eye's fluid remains open, but the fluid doesn't drain properly.
• Acute angle-closure glaucoma: A more severe form where the drainage angle becomes blocked, causing a sudden, sharp increase in eye pressure. Pilocarpine can help open this angle.
• Ocular hypertension: When the pressure in your eye is higher than normal but without optic nerve damage yet, pilocarpine can help prevent the development of glaucoma.

It can also be used to reverse the effects of certain medications that dilate the pupils (mydriasis), for example, after an eye exam.

How It Works

Pilocarpine ophthalmic belongs to a class of drugs called miotics. When applied to the eye, it acts on specific receptors, causing the pupil to constrict (miosis) and the ciliary muscle within the eye to contract. This contraction pulls on the trabecular meshwork, a sponge-like tissue located at the base of the cornea, increasing the outflow of aqueous humor (the fluid inside the eye). By facilitating better drainage of this fluid, pilocarpine effectively lowers intraocular pressure, thereby reducing the risk of optic nerve damage associated with glaucoma.

Typical Costs of Pilocarpine Ophthalmic

The cost of pilocarpine ophthalmic can vary significantly. Factors influencing the price include whether you're prescribed a generic or brand-name version, the specific dosage and formulation (e.g., eye drops, gel), the pharmacy you use, and your insurance coverage. Without insurance, a generic prescription for pilocarpine ophthalmic eye drops might range from $30 to over $100 for a single bottle. Brand-name versions can be considerably more expensive. These costs can add up, especially for a medication that often requires long-

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Pilocarpine Ophthalmic is approved for (FDA label)

Pilocarpine hydrochloride ophthalmic solution, is indicated for the: Pilocarpine hydrochloride ophthalmic solution, USP is a muscarinic cholinergic agonist indicated for The reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (1.1) The management of acute angle-closure glaucoma (1.2) The prevention of postoperative elevated IOP associated with laser surgery (1.3) The induction of miosis (1.4) 1.1 Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-Angle Glaucoma or Ocular Hypertension 1.2 Management of Acute Angle-Closure Glaucoma 1.3 Prevention of Postoperative Elevated IOP Associated with Laser Surgery 1.4 Induction of Miosis

Source: Read the full FDA label on DailyMed. Label effective date: December 22, 2025.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Pilocarpine Ophthalmic (FDA label)

Bottle filled with 15 mL of 1% (10 mg/mL), 2% (20 mg/mL) or 4% (40 mg/mL) pilocarpine hydrochloride sterile ophthalmic solution. Solution containing 1% (10 mg/mL), 2% (20 mg/mL) or 4% (40 mg/mL) pilocarpine hydrochloride (3)

Source: FDA prescribing information (DailyMed). Set ID: 84428e9a-f486-44d9-ad93-4ea9069a6787. SPL document ID: 82a2d0b0-5ac5-46a1-b945-1f5669cc75ec. Label effective date: December 22, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Pilocarpine Ophthalmic (FDA label)

Clinical Studies Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety data described below reflect exposure in four controlled clinical trials of 90 days to 2 years duration in 317 patients diagnosed with open-angle glaucoma or ocular hypertension. In the four clinical trials, patients were treated with pilocarpine hydrochloride ophthalmic solution 2%, two to four times daily or with pilocarpine 1%, 1.75% or 2% in fixed combination with betaxolol 0.25%, two or three times daily. The most frequently reported adverse reactions occurring in ≥ 5% of patients in the pilocarpine 2% populations were: headache/browache, accommodative change, blurred vision, eye irritation, visual impairment (dim, dark, or "jumping" vision), and eye pain. The adverse reaction profile reported for the use of pilocarpine hydrochloride ophthalmic solution in pediatric patients is comparable to that seen in adult patients. Most common adverse reactions are headache/browache, accommodative change, eye irritation, eye pain, blurred vision, and/or visual impairment (6.1).

Source: FDA prescribing information (DailyMed). Set ID: 84428e9a-f486-44d9-ad93-4ea9069a6787. SPL document ID: 82a2d0b0-5ac5-46a1-b945-1f5669cc75ec. Label effective date: December 22, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Pilocarpine Ophthalmic (FDA label)

Poor illumination: Exercise caution in night driving and other hazardous occupations in poor illumination (5.1). Pre-existing retinal disease: Rare cases of retinal detachment have been reported; a thorough examination of the retina including funduscopy is advised in all patients prior to the initiation of therapy (5.2). Iritis: Caution is advised in patients with iritis. (5.3) Congenital glaucoma: Caution is advised in pediatric patients with primary congenital glaucoma for control of IOP as cases of a paradoxical increase in IOP have been reported. (5.4) 5.1 Poor Illumination Patients should be advised to exercise caution in night driving and other hazardous occupations in poor illumination. In addition, miotics may cause accommodative spasm.

Source: FDA prescribing information (DailyMed). Set ID: 84428e9a-f486-44d9-ad93-4ea9069a6787. SPL document ID: 82a2d0b0-5ac5-46a1-b945-1f5669cc75ec. Label effective date: December 22, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.